Vor Biopharma, Inc. (VOR)
11.65
-1.43
(-10.93%)
USD |
NASDAQ |
Jan 02, 16:00
11.65
0.00 (0.00%)
After-Hours: 16:06
Vor Biopharma Research and Development Expense (TTM): 327.69M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Outset Medical, Inc. | 23.19M |
| iBio, Inc. | 10.56M |
| Salarius Pharmaceuticals, Inc. | 0.4291M |
| Senti Biosciences, Inc. | 36.69M |
| NovaBay Pharmaceuticals, Inc. | -- |